Tempus AI, Inc. (NASDAQ:TEM) CFO Sells $1,058,689.10 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 23,030 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.97, for a total transaction of $1,058,689.10. Following the completion of the transaction, the chief financial officer now directly owns 164,750 shares in the company, valued at $7,573,557.50. This trade represents a 12.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

James William Rogers also recently made the following trade(s):

• On Tuesday, February 18th, James William Rogers sold 31,780 shares of Tempus AI stock. The stock was sold at an average price of $82.33, for a total value of $2,616,447.40.
• On Wednesday, February 5th, James William Rogers sold 8,712 shares of Tempus AI stock. The stock was sold at an average price of $67.57, for a total value of $588,669.84.

Tempus AI Stock Up 5.0 %

TEM traded up $2.29 during trading hours on Wednesday, hitting $48.03. 11,624,616 shares of the company’s stock were exchanged, compared to its average volume of 5,018,008. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45. The firm has a 50 day moving average of $55.86 and a 200 day moving average of $51.48. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Institutional Trading of Tempus AI

A number of large investors have recently modified their holdings of TEM. First Horizon Advisors Inc. purchased a new stake in Tempus AI during the 3rd quarter worth about $30,000. Operose Advisors LLC purchased a new stake in Tempus AI during the 4th quarter worth about $25,000. Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI during the fourth quarter worth approximately $34,000. Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the period. Finally, NewEdge Advisors LLC purchased a new stake in shares of Tempus AI during the fourth quarter worth approximately $49,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. JPMorgan Chase & Co. lowered shares of Tempus AI from an “overweight” rating to a “neutral” rating and lifted their price target for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. William Blair restated a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Finally, Morgan Stanley upped their target price on shares of Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.